- Investing Ideas
- /
- U.S. Large Cap High Growth Potential
U.S. Large Cap High Growth Potential
Results
231
9 new
Large Cap Companies that analysts expect to have high earnings, revenue or cash flow growth in the next 3 years.
231 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
NVDA | US$131.28 | -5.7% | 69.0% | US$3.1t | US$171.64 | PE51x | E21.7% | 0.03% | Semiconductors | ||
ONON | US$49.89 | -4.2% | 45.7% | US$15.5b | US$63.68 | PE113.3x | E29.8% | n/a | Consumer Durables | ||
ALNY | US$243.86 | -2.7% | 57.1% | US$31.7b | US$304.61 | PS14x | E58.7% | n/a | Pharmaceuticals & Biotech | ||
ARES | US$168.97 | -9.5% | 28.7% | US$52.4b | US$198.57 | PE77.4x | E41.4% | 2.7% | Diversified Financials | ||
NU | US$11.48 | -13.9% | 3.6% | US$55.3b | US$14.59 | PB7.2x | E24.4% | n/a | Banks | ||
ALAB | US$83.00 | -7.7% | n/a | US$12.6b | US$125.03 | PS34x | E61.1% | n/a | Semiconductors | ||
ITCI | US$128.46 | -0.1% | 80.6% | US$13.7b | US$132.00 | PS20.1x | E50.2% | n/a | Pharmaceuticals & Biotech | ||
SMCI | US$51.11 | -15.2% | -37.4% | US$27.0b | US$50.06 | PE21x | E29.1% | n/a | Tech | ||
SYM | US$23.72 | -11.4% | -40.0% | US$13.8b | US$34.20 | PS1.3x | E84.6% | n/a | Capital Goods | ||
PLTR | US$89.31 | -16.0% | 256.1% | US$209.5b | US$87.38 | PE453.2x | E28.4% | n/a | Software | ||
ZS | US$195.82 | -8.8% | -17.5% | US$29.6b | US$227.35 | PS13.1x | E39.7% | n/a | Software | ||
SRPT | US$106.86 | -0.2% | -22.3% | US$10.2b | US$181.78 | PE83.8x | E30.1% | n/a | Pharmaceuticals & Biotech | ||
EXEL New | US$37.53 | 7.0% | 71.3% | US$10.3b | US$37.10 | PE20.2x | E21.2% | n/a | Pharmaceuticals & Biotech | ||
EXE | US$102.43 | -4.7% | 24.8% | US$23.8b | US$117.92 | PE93.2x | E64.4% | 2.2% | Energy | ||
VRT | US$98.61 | -8.6% | 49.2% | US$35.0b | US$136.62 | PE75.7x | E24.8% | 0.2% | Capital Goods | ||
CVNA | US$232.63 | -17.5% | 208.2% | US$47.8b | US$274.66 | PE148.5x | E31.3% | n/a | Retail | ||
XPEV | US$21.99 | 22.2% | 151.9% | US$18.2b | US$15.46 | PS4x | E57.8% | n/a | Automobiles | ||
NTNX | US$69.35 | -3.8% | 17.5% | US$17.9b | US$81.91 | PS8.3x | E91.8% | n/a | Software | ||
SPOT | US$603.13 | -6.2% | 139.1% | US$120.0b | US$644.47 | PE103x | E23.6% | n/a | Media | ||
RYAN | US$69.00 | -0.5% | 35.9% | US$18.1b | US$75.60 | PE91.6x | E62.2% | 0.7% | Insurance | ||
WIX | US$199.16 | -8.2% | 43.0% | US$11.2b | US$243.39 | PE80.6x | E27.6% | n/a | Software | ||
MRVL | US$94.90 | -14.5% | 40.5% | US$80.5b | US$129.56 | PS15.3x | E55.5% | 0.3% | Semiconductors | ||
CRWD | US$394.56 | -12.3% | 22.9% | US$93.5b | US$397.89 | PE767x | E37.4% | n/a | Software | ||
ARM | US$138.97 | -10.0% | 3.8% | US$144.1b | US$158.43 | PE181.7x | E29.0% | n/a | Semiconductors |